|
1
|
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
J Clin Oncol
|
2014
|
3.07
|
|
2
|
Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
|
JAMA
|
2006
|
2.73
|
|
3
|
Risk of pancreatic cancer in families with Lynch syndrome.
|
JAMA
|
2009
|
2.32
|
|
4
|
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
|
Lancet Oncol
|
2010
|
1.98
|
|
5
|
Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
|
Clin Gastroenterol Hepatol
|
2004
|
1.76
|
|
6
|
Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
|
Am J Gastroenterol
|
2013
|
1.71
|
|
7
|
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.
|
Cancer Prev Res (Phila)
|
2012
|
1.65
|
|
8
|
Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy.
|
Am J Gastroenterol
|
2009
|
1.62
|
|
9
|
Colon cancer, version 3.2014.
|
J Natl Compr Canc Netw
|
2014
|
1.59
|
|
10
|
Factors associated with enrollment in cancer genetics research.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.31
|
|
11
|
Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.16
|
|
12
|
Elevated risk of prostate cancer among men with Lynch syndrome.
|
J Clin Oncol
|
2013
|
1.14
|
|
13
|
Gastric cancer in individuals with Li-Fraumeni syndrome.
|
Genet Med
|
2011
|
1.05
|
|
14
|
Adrenocortical carcinoma is a lynch syndrome-associated cancer.
|
J Clin Oncol
|
2013
|
1.02
|
|
15
|
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.
|
J Clin Oncol
|
2009
|
0.96
|
|
16
|
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.
|
Gynecol Oncol
|
2012
|
0.94
|
|
17
|
Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.
|
Am J Gastroenterol
|
2007
|
0.90
|
|
18
|
The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
|
J Clin Endocrinol Metab
|
2014
|
0.84
|
|
19
|
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2017
|
0.83
|
|
20
|
A multidisciplinary approach to the diagnosis and management of multiple colorectal polyps.
|
Gastroenterol Hepatol (N Y)
|
2011
|
0.82
|
|
21
|
Adenomas in young patients: what is the optimal evaluation?
|
Am J Gastroenterol
|
2005
|
0.81
|
|
22
|
Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
|
Fam Cancer
|
2012
|
0.79
|
|
23
|
Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.
|
Fam Cancer
|
2011
|
0.77
|
|
24
|
Familial gastric and pancreatic cancers: Diagnosis and screening.
|
Am Soc Clin Oncol Educ Book
|
2013
|
0.76
|
|
25
|
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
|
JAMA Dermatol
|
2014
|
0.76
|
|
26
|
Preventing missed colorectal cancers: is "rear view" the answer?
|
Gastrointest Endosc
|
2011
|
0.75
|
|
27
|
Practical considerations for implementing genomic information resources. Experiences from eMERGE and CSER.
|
Appl Clin Inform
|
2016
|
0.75
|
|
28
|
An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome.
|
Clin Endocrinol (Oxf)
|
2013
|
0.75
|
|
29
|
CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.
|
Semin Colon Rectal Surg
|
2011
|
0.75
|
|
30
|
Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals.
|
Fam Cancer
|
2015
|
0.75
|
|
31
|
Delayed Workup of Rectal Bleeding in Adult Primary Care: Examining Process-of-Care Failures.
|
Jt Comm J Qual Patient Saf
|
2016
|
0.75
|